ClinicalTrials.govpublic full text
A Study to Evaluate MRG003 vs Cetuximab/Methotrexate in in the Treatment of Patients With RM-SCCHN
squamous cell carcinoma of the head and neck, mrg003, antibody drug conjugate (adc), scchn, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 837251
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.